LX7101 is a potent LIM-kinase, ROCK and PKA inhibitor with IC50s of 24 nM, 1.6 nM, 10 nM and 50 values of 4.3 nM and 32 nM for LIMK2 and LIMK1 at 2 µM ATP, respectively. LX7101 has the potential for ocular hypertension and associated glaucoma research[1][2].
Molecular Weight:
451.52
Purity:
99.54
CAS Number:
[1192189-69-7]
Formula:
C23H29N7O3
Target:
LIM Kinase (LIMK),PKA,ROCK
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
